(Q38426799)

3 September 2017

1 reference

title

Indirubin derivatives: a patent review (2010 - present). (English)

1 reference

Konstantina Vougogiannopoulou

3 September 2017

author

object named as

Konstantina Vougogiannopoulou

series ordinal

2

0 references

Alexios-Leandros Skaltsounis

series ordinal

3

object named as

Alexios-Leandros Skaltsounis

1 reference

3 September 2017

author name string

Nicolas Gaboriaud-Kolar

series ordinal

1

1 reference

3 September 2017

language of work or name

English

0 references

publication date

1 May 2015

1 reference

Expert Opinion on Therapeutic Patents

3 September 2017

published in

1 reference

3 September 2017

volume

25

1 reference

3 September 2017

issue

5

1 reference

3 September 2017

page(s)

583-593

1 reference

Royal Purple dye: the chemical reconstruction of the ancient Mediterranean industry

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

Tyrian Purple: 6,6’-Dibromoindigo and Related Compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

Sex-specific Tyrian purple genesis: precursor and pigment distribution in the reproductive system of the marine mollusc, Dicathais orbita.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

Generation of new protein kinase inhibitors utilizing cytochrome p450 mutant enzymes for indigoid synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

GSK-3-selective inhibitors derived from Tyrian purple indirubins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

From the insoluble dye indirubin towards highly active, soluble CDK2-inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

Synthesis of novel 5-substituted indirubins as protein kinases inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

Structural basis for the synthesis of indirubins as potent and selective inhibitors of glycogen synthase kinase-3 and cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

Novel Inverse Binding Mode of Indirubin Derivatives Yields Improved Selectivity for DYRK Kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

Indirubin derivatives as potent FLT3 inhibitors with anti-proliferative activity of acute myeloid leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

Dual inhibition of Janus and Src family kinases by novel indirubin derivative blocks constitutively-activated Stat3 signaling associated with apoptosis of human pancreatic cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

7,7'-Diazaindirubin--a small molecule inhibitor of casein kinase 2 in vitro and in cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

7-Bromoindirubin-3'-oxime induces caspase-independent cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

Independent actions on cyclin-dependent kinases and aryl hydrocarbon receptor mediate the antiproliferative effects of indirubins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

6-Br-5methylindirubin-3'oxime (5-Me-6-BIO) targeting the leishmanial glycogen synthase kinase-3 (GSK-3) short form affects cell-cycle progression and induces apoptosis-like death: exploitation of GSK-3 for treating leishmaniasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

An inhibitor-driven study for enhancing the selectivity of indirubin derivatives towards leishmanial Glycogen Synthase Kinase-3 over leishmanial cdc2-related protein kinase 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

Inhibition of Toxoplasma gondii by indirubin and tryptanthrin analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

Synthesis and antiproliferative activity of 7-azaindirubin-3'-oxime, a 7-aza isostere of the natural indirubin pharmacophore.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

Enhanced indirubin production in recombinant Escherichia coli harboring a flavin-containing monooxygenase gene by cysteine supplementation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

BCR-ABL gene expression is required for its mutations in a novel KCL-22 cell culture model for acquired resistance of chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

Src kinase signaling in leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

Bcr-Abl activates AURKA and AURKB in chronic myeloid leukemia cells via AKT signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

Janus kinase 2: a critical target in chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

Signal transduction therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

Indirubin derivative 6BIO suppresses metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

The pleiotropic profile of the indirubin derivative 6BIO overcomes TRAIL resistance in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

6-Bromoindirubin-3'-oxime inhibits JAK/STAT3 signaling and induces apoptosis of human melanoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

5,5'-substituted indirubin-3'-oxime derivatives as potent cyclin-dependent kinase inhibitors with anticancer activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

Chemistry and biochemistry of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

Roles of the Akt/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

GSK3beta positively regulates Hedgehog signaling through Sufu in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

Role of glycogen synthase kinase-3 in cancer: regulation by Wnts and other signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

Aberrant nuclear accumulation of glycogen synthase kinase-3beta in human pancreatic cancer: association with kinase activity and tumor dedifferentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

Glycogen synthase kinase-3 beta; a new target in pancreatic cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

Role of Src expression and activation in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

Kinases as targets in the treatment of solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

Establishing the role of tyrosine kinase 2 in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

A novel 7-bromoindirubin with potent anticancer activity suppresses survival of human melanoma cells associated with inhibition of STAT3 and Akt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

Wnt signaling in neuroprotection and stem cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

Control of stem cells and cancer stem cells by Hedgehog signaling: pharmacologic clues from pathway dissection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

Glycogen synthase kinase 3: more than a namesake

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

Stable generation of serum- and feeder-free embryonic stem cell-derived mice with full germline-competency by using a GSK3 specific inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

Soluble 3',6-substituted indirubins with enhanced selectivity toward glycogen synthase kinase -3 alter circadian period

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

Enhancement of oral bioavailability of E804 by self-nanoemulsifying drug delivery system (SNEDDS) in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

Substitution and chemical environment effects on the absorption spectrum of indigo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

Identification of the Coloring Constituents of Four Natural Indigoid Dyes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

21 January 2018

Origin of Indigo of Woad

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2015.1019865

Qualitative analysis of indigo precursors from woad by HPLC and HPLC-MS

21 January 2018

1 reference

11 May 2024

https://opencitations.net/index/api/v1/citations/10.1002/(SICI)1099-1565(200001/02)11:1%3C18::AID-PCA483%3E3.0.CO;2-X

Identifiers

DOI

10.1517/13543776.2015.1019865

1 reference

3 September 2017

1 reference